Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) — Cash Flow-to-Debt Ratio
Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥8.20 Million could theoretically repay 0% of its total liabilities (CN¥658.86 Million) in one year. See Jilin Jian Yisheng Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jilin Jian Yisheng Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Jilin Jian Yisheng Pharmaceutical Co Ltd across 20 annual periods. Also explore net asset momentum of Jilin Jian Yisheng Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jilin Jian Yisheng Pharmaceutical Co Ltd (2006–2025)
Year-by-year debt coverage analysis for Jilin Jian Yisheng Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jilin Jian Yisheng Pharmaceutical Co Ltd (002566) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥98.74 Million | CN¥630.35 Million | ▲ +69.3% |
| 2024 | 0.09x | CN¥58.94 Million | CN¥637.22 Million | ▼ -68.4% |
| 2023 | 0.29x | CN¥209.13 Million | CN¥714.30 Million | ▲ +44.0% |
| 2022 | 0.20x | CN¥145.86 Million | CN¥717.18 Million | ▼ -37.0% |
| 2021 | 0.32x | CN¥215.10 Million | CN¥666.08 Million | ▲ +5.3% |
| 2020 | 0.31x | CN¥203.51 Million | CN¥663.86 Million | ▼ -36.2% |
| 2019 | 0.48x | CN¥210.87 Million | CN¥438.66 Million | ▲ +68.8% |
| 2018 | 0.28x | CN¥167.32 Million | CN¥587.49 Million | ▼ -20.4% |
| 2017 | 0.36x | CN¥270.65 Million | CN¥756.40 Million | ▲ +1875.9% |
| 2016 | -0.02x | CN¥-17.52 Million | CN¥869.67 Million | ▲ +94.5% |
| 2015 | -0.36x | CN¥-324.29 Million | CN¥888.65 Million | ▲ +54.4% |
| 2014 | -0.80x | CN¥-592.06 Million | CN¥739.24 Million | ▲ +9.1% |
| 2013 | -0.88x | CN¥-188.45 Million | CN¥213.79 Million | ▼ -181.2% |
| 2012 | 1.09x | CN¥79.08 Million | CN¥72.81 Million | ▲ +162.5% |
| 2011 | -1.74x | CN¥-112.12 Million | CN¥64.52 Million | ▼ -633.3% |
| 2010 | 0.33x | CN¥50.73 Million | CN¥155.66 Million | ▼ -61.8% |
| 2009 | 0.85x | CN¥125.25 Million | CN¥146.67 Million | ▲ +430.9% |
| 2008 | 0.16x | CN¥20.50 Million | CN¥127.43 Million | ▼ -73.5% |
| 2007 | 0.61x | CN¥82.66 Million | CN¥136.08 Million | ▲ +135.9% |
| 2006 | 0.26x | CN¥25.58 Million | CN¥99.35 Million | — |